ASX - By Stock
|
MSB |
Re:
Ann: US$45 Million Private Placement to Major Shareholders
|
|
nathank123
|
321 |
104K |
3 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
321
|
104K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB 2022 - The road to commercialisation
|
|
nathank123
|
1.5K |
510K |
3 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
1.5K
|
510K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDAs OTAT Agrees to Primary Endpoint for Back Pain
|
|
nathank123
|
408 |
125K |
6 |
16/12/21 |
16/12/21 |
ASX - By Stock
|
408
|
125K
|
6
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nathank123
|
10K |
3.0M |
5 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nathank123
|
10K |
3.0M |
4 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Greatest Benefit in Diabetics and Ischemics
|
|
nathank123
|
304 |
96K |
4 |
06/12/21 |
06/12/21 |
ASX - By Stock
|
304
|
96K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CEO Presentation to 2021 Annual General Meeting
|
|
nathank123
|
54 |
18K |
10 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
54
|
18K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q1 Financial Results and Operational Highlights
|
|
nathank123
|
124 |
39K |
3 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
124
|
39K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q1 Financial Results Webcast
|
|
nathank123
|
64 |
20K |
1 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
64
|
20K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility
|
|
nathank123
|
451 |
115K |
6 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
451
|
115K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility
|
|
nathank123
|
451 |
115K |
4 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
451
|
115K
|
4
|
|
ASX - By Stock
|
A2M |
Re:
Todays A2M meeting.
|
|
nathank123
|
77 |
23K |
0 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
77
|
23K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CHF Late Breaker Presentation at American Heart Association
|
|
nathank123
|
350 |
127K |
0 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
350
|
127K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L Improves Survival in High-Risk Acute GvHD
|
|
nathank123
|
116 |
49K |
8 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
116
|
49K
|
8
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nathank123
|
10K |
3.0M |
2 |
16/09/21 |
16/09/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
FY22 - It's all to play for here!
|
|
nathank123
|
145 |
42K |
2 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
145
|
42K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
nathank123
|
77 |
22K |
1 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
77
|
22K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
nathank123
|
18K |
6.9M |
2 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
18K
|
6.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
nathank123
|
18K |
6.9M |
2 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
18K
|
6.9M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nathank123
|
10K |
3.0M |
19 |
24/08/21 |
24/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Guess the Full Year Loss in this year's Annual Report
|
|
nathank123
|
38 |
6.2K |
1 |
23/08/21 |
23/08/21 |
ASX - By Stock
|
38
|
6.2K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nathank123
|
10K |
3.0M |
5 |
21/08/21 |
21/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nathank123
|
10K |
3.0M |
5 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
nathank123
|
10K |
3.2M |
3 |
08/08/21 |
08/08/21 |
ASX - By Stock
|
10K
|
3.2M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Release of Shares from Voluntary Escrow
|
|
nathank123
|
28 |
12K |
5 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
28
|
12K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
nathank123
|
10K |
3.2M |
11 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
10K
|
3.2M
|
11
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
nathank123
|
10K |
3.2M |
4 |
10/07/21 |
10/07/21 |
ASX - By Stock
|
10K
|
3.2M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
nathank123
|
340 |
115K |
2 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
340
|
115K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
nathank123
|
340 |
115K |
3 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
340
|
115K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nathank123
|
10K |
3.0M |
6 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
10K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
nathank123
|
340 |
115K |
10 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
340
|
115K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
nathank123
|
340 |
115K |
5 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
340
|
115K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on Chronic Low Back Pain Program
|
|
nathank123
|
340 |
115K |
4 |
01/07/21 |
01/07/21 |
ASX - By Stock
|
340
|
115K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
nathank123
|
18K |
6.9M |
1 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
18K
|
6.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
nathank123
|
18K |
6.9M |
1 |
29/06/21 |
29/06/21 |
ASX - By Stock
|
18K
|
6.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
nathank123
|
18K |
6.9M |
1 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
18K
|
6.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
nathank123
|
18K |
6.9M |
1 |
28/06/21 |
28/06/21 |
ASX - By Stock
|
18K
|
6.9M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Where is Novartis?
|
|
nathank123
|
1.5K |
418K |
9 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
1.5K
|
418K
|
9
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nathank123
|
10K |
3.0M |
1 |
30/05/21 |
30/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
nathank123
|
18K |
6.9M |
2 |
26/05/21 |
26/05/21 |
ASX - By Stock
|
18K
|
6.9M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Remestemcel-L for COPD Published in Respiratory Research
|
|
nathank123
|
91 |
30K |
5 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
91
|
30K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nathank123
|
10K |
3.0M |
7 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
10K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nathank123
|
10K |
3.0M |
0 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
nathank123
|
10K |
3.0M |
6 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cup and Handle Chart Pattern
|
|
nathank123
|
249 |
56K |
1 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
249
|
56K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cup and Handle Chart Pattern
|
|
nathank123
|
249 |
56K |
5 |
15/03/21 |
15/03/21 |
ASX - By Stock
|
249
|
56K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Meso holders only
|
|
nathank123
|
105 |
25K |
3 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
105
|
25K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Meso holders only
|
|
nathank123
|
105 |
25K |
0 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
105
|
25K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Holders Only
|
|
nathank123
|
518 |
147K |
2 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
518
|
147K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
nathank123
|
5.7K |
2.8M |
1 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
5.7K
|
2.8M
|
1
|
|